Ayodhya’s Rajarshi Dashrath Medical College set to open 110-bed trauma centre by May 2025

Ayodhya: As part of the state government’s scheme to develop Ayodhya into a hub of health and wellness, the Uttar Pradesh government has greenlit the construction of a state-of-the-art 110-bed trauma centre at the Rajarshi Dashrath Medical College, Darshan Nagar, Ayodhya.  

The project with an estimated budget of Rs 33 crore, is expected to be completed by May 2025. The facility will include a 50-bed trauma centre and a 60-bed emergency medicine department, providing comprehensive emergency medical services with a total capacity of 110 beds.  

It will offer comprehensive modern healthcare services to patients under one roof, which will save the residents of Ayodhya from travelling to Lucknow for the treatment of emergency cases. Ayodhya will become a hub of both spirituality and advanced healthcare.  

Also read- Ram Mandir Pran Pratishtha: Beds reserved at district hospitals, AIIMS experts training doctors

According to an official spokesperson, the trauma centre is part of the broader blueprint for Ayodhya’s development, which began with the construction of the Ram Temple. 

“Concerned about the health needs of both residents and devotees, CM Yogi has directed the expansion of facilities at the multi-speciality hospital and Rajarshi Dashrath Medical College in Darshan Nagar,” the spokesperson told TOI

Following government approval, the UP State Construction and Infrastructure Development Corporation Limited (UPSIDCO) initiated the project, and 50 per cent of the work on the three-storey building has already been completed.

Speaking to Daily Pioneer, Principal Dr Gyanendra Kumar said, “The construction is progressing rapidly, and the centre will also feature a modern lift for added convenience. This trauma centre will be a major asset for critically ill patients, offering all necessary services in one place, eliminating the need for patients and their families to travel between facilities.”  

Also Read: CMC Vellore gets Rs 500 crore grant from Azim Premji Foundation to set up a new medical college at Chittoor

Powered by WPeMatico

DCI directs Dental Colleges to implement measures to curb ragging menace

Delhi: The Dental Council of India (DCI) has issued guidelines for curbing the menace of ragging in dental institutions.

Writing to the Principals/Heads of all the Dental Colleges in the Country, the DCI stated that it is the responsibility of all institutions to ensure that no incident of ragging takes place n their dental institution and measures taken to curb it may be reviewed as DCI Regulations on Curbing the Menace of Ragging in Dental Colleges, 2009.

As per section 11.3 of the regulations above, the authorities/Management (Trust, Societies, etc.) of the institution, particularly the Head of the institution, shall be responsible for ensuring that no incident of ragging takes place in the institution. In case any ragging incident occurs, the Management/Head shall take prompt and appropriate action against the person(s) whose dereliction of duty lead to the incident. In its turn, the authority designated to appoint the Head shall take prompt and appropriate action against the Head.

Further, DCI has instructed all dental institutions should issue advertisements against ragging through signboards, pamphlets etc. before the commencement of academic year as well as during the midst of the session and also to issue booklets to all the students of your Institutions containing the details about what constitutes ragging, punishable ingredients of ragging, punishments and penalty for ragging, names and mobile numbers of the members of the Anti Ragging Squad, Anti Ragging Committee (Anti Ragging Helpline), Wardens, Deputy Wardens of Men’s and Women’s hostel.

All dental Institutions will have to designate any of their faculty member(s) as “Counsellor” for fresher and senior students to coordinate the batches of students (Counselees) regularly about day-to-day problems and also to sensitize their role in curbing the menace of ragging.

The dental colleges will have to obtain and file an undertaking, on anti-ragging, from all parents/guardians and students (1st year to final year) studying in BDS/MDS/PG Diploma/Para Dental Courses or any other course approved/recognized by DCI

Besides above, it is also pertinent to mention here that, as per section 12.1 of subject regulations, each and every institution shall submit its reports by 31st October of every year in which admissions are made, indicating the action taken by institution for implementation of Regulation 9.1 & 9.2 of said regulations failing which the Dental Council of India, 

In case the institutes fail to submit the report, then DCI, as per section 11.4 of Regulations on Curbing the Menace of Ragging in Dental Colleges, 2009, shall impose any one or any combination of the following penalties on it –

To initiate the derecognition process against the institution under section 16A of the Dentists Act, 1948

To reduce the admission capacity of the institution to the extent to which the Council deem fit.

To stop further admission in the institution till further orders.

To stop renewal of permission in respect of UG/PG Dental Courses.

To post the information regarding penalties so imposed on the concerned institution on the website of DCI for information of all concerned.

DCI has developed an online module to upload the requisite information/documents on its website to reduce the paperwork and efficiently scrutinize the above data. The Executive Committee of the DCI, in its meeting held on 13th October 2018 in New Delhi, has decided that all the requisite information/documents required as per DCI Regulations on Curbing the Menace of Ragging in Dental Colleges, 2009 shall be uploaded on the DCI website and any hard copy of information /documents received by Post or sent by E-mail shall not be considered by DCI.

DCI stated that it is mandatory for all the institutions to upload the Anti Ragging Report, October 2024 on DCI Anti Ragging Online Module by using the online portal, as per the Monitoring Committee appointed by the Hon’ble Supreme Court of India and as per DCI Regulations on Curbing the Menace of Ragging in Dental Colleges, 2009, latest by 31.10.2024, positively. In case the requisite information is not uploaded by 31.10.2024 on DCI Anti Ragging Online Module, the name of defaulting college/institution will be forwarded to the said Monitoring Committee for appropriate action and their names will also be uploaded on DCI Website.

It is again reiterated that only the uploaded Anti Ragging Report, Oct. 2024 will be considered by the council and no hard copy/emails will be considered as report submission. Compliance to this circular may be treated as most urgent since the DCI Anti Ragging Online Module will automatically get disabled for uploading October 2024 Anti Ragging Report after 31.10.2024 (Midnight), the dental council said.

To view the official Notice, Click here :  https://medicaldialogues.in/pdf_upload/5791-256276.pdf

Powered by WPeMatico

Biotechnology to Drive India’s Next Industrial Revolution: Dr. Jitendra Singh

New Delhi: Union Minister of State for Science and Technology, Jitendra Singh, highlighted India’s expanding role as a global leader in affordable, high-quality healthcare and medical tourism, which has emerged as a major source of revenue.

Singh was addressing the CII 6th Pharma and Life Sciences Summit 2024 in New Delhi on Wednesday as he expressed government’s commitment to supporting the biotechnology sector, referencing the launch of venture funds and policies that have spurred significant growth in biotech startups.

“The number of biotech start-ups has risen from just 50 in 2014 to over 5,000 now, reflecting India’s increasing focus on bio economy and urged for stronger collaboration between the public and private sectors,” Singh said.
Singh also highlighted the need to create a robust research ecosystem, with biotechnology being a focal point for the next industrial revolution.
Singh further emphasized on the growth of India’s bioeconomy, which has seen a ten-fold increase since 2014, and reiterated the need for an inclusive innovation ecosystem that balances intellectual property, data protection, and clinical trials.
His remarks reflected optimism for India’s role as a global leader in healthcare and biotechnology, while also addressing the challenges and opportunities ahead.
Dr Arunish Chawla, Secretary, Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, Government of India, underscored the significant milestones of, the pharmaceuticals and biotechnology sector “Last month, the pharmaceuticals and biotechnology became the 4th largest export manufacturing Industry for India. India is aiming to be a reliable pharmacy of the world and a futuristic global leader in both biotechnology and life sciences”.
Dr Rajesh S Gokhale, Secretary, Department of Biotechnology, Ministry of Science and Technology, Government of India in his address emphasized on the futuristic role that biotechnology can play in the progress of India, highlighting global recognition and collaboration.
He underscored the BioE3 Policy – the importance of biotechnology in driving economic growth, protecting the environment, and generating employment. He noted that India’s path towards ‘Viksit Bharat 20247’ requires breaking out of the ‘middle-income trap’, a challenge faced by several countries.
Dr Rajeev Singh Raghuvanshi, Drugs Controller General India, Central Drugs Standard Control Organization (CDSCO) highlighted India’s strides toward becoming the ‘pharmacy of the world’, commending regulatory improvements under CDSCO.
He emphasized India’s commitment to global public health through collaborative efforts, including new approaches to streamline drug approvals, reduce delays, and increase efficiency.
Dr Vinod K Paul, Member, NITI Aayog highlighted the significant milestones achieved in pandemic preparedness, emphasizing the importance of collaboration across government, industry, and research ecosystems. He outlined four key focus areas: government policy, data management, innovation & manufacturing, and global partnerships. He stressed the need for proactive R&D, particularly in developing countermeasures for future pandemics, and the necessity of preparedness through rapid vaccine development.
Dr Rajesh Jain, Chairman, CII National Committee on Biotechnology and Chairman & Managing Director, Panacea Biotec Ltd) in his address highlighted the need for the pharmaceutical and biotechnology sectors to triple in size, aiming to reach USD 300 billion by 2047.
The CII Life Sciences Summit is an annual flagship thought leadership platform. It is a synergistic combination of the pharmaceutical and biotechnology sectors and a platform dedicated to discuss the impact of the regulatory reforms, recent technological trends, fostering cutting-edge innovations, the future of biologics and biosimilar, developing skilled talent, ensuring equitable healthcare, and other prevalent advocacy matters.

Powered by WPeMatico

Fortis Healthcare to Raise ₹1,500 Crore Through NCDs

New Delhi: Fortis Healthcare Ltd recently announced that its board has approved raising up to Rs 1,500 crore through the issuance of non-convertible debentures via private placement.
The company’s board of directors at its meeting held on October 9, 2024, considered and approved issue of non-convertible debentures (NCDs) on a private placement basis to eligible investors, according to a regulatory filing.
In the filing, the healthcare company said that the eligible investors include but are not limited to identified anchor investors DBS Bank Ltd (DBS), The Hongkong and Shanghai Banking Corporation Ltd (HSBC), Citicorp Investment Bank (Singapore) Ltd., Mizuho Bank, Singapore and other foreign portfolio investors qualified during the bidding process.
The sum is planned to be raised through three series with DBS Bank Ltd as anchor investor for Series 1 for up to Rs 500 crore; HSBC through its GIFT FPI as anchor investor for Series 2 of up to Rs 500 crore; and Citicorp Investment Bank (Singapore) Ltd, Mizuho Bank, Singapore as anchor investors of Series 3 of Rs 500 crore.
The NCDs will have a tenure of 5 years from the date of allotment and are proposed to be listed on BSE, the company said.
Shares of Fortis Healthcare settled 1.73 per cent higher at Rs 607.40 per piece on the BSE.

Powered by WPeMatico

RG Kar Protests disrupt Kolkata restaurants, causing revenue decline

Kolkata: Protests in Kolkata continue following the rape and murder of a woman doctor at R G Kar Medical College and Hospital, significantly impacting the food and beverage industry in the city. Restaurant owners report a 15-20% drop in revenue over the past month, though recent festivities have led to a cautious uptick in customer turnout.  

However, as table occupancy has increased over the past week due to the festivities, restaurant and café owners remained cautiously optimistic, even as protests continued simultaneously in the city. 

Sudip Mallick, owner of Bonne Femme café, told PTI, “Turnout of patrons had dwindled during evening hours on weekdays for over a month, except on weekends. But since Monday, October 2 (the day of Mahalaya), the 46-seater place has been recording 100 per cent occupancy.”

Also Read:Kolkata Doctor Rape-Murder: Delhi Doctors stage hunger strike, candle march showing solidarity

“Continuing agitation reflected the discontent and anger in people’s minds. While the buzz in the market is typically felt a month before the festival in other years, this year the situation is different,” he added.

According to the PTI report, Mallick, who also operates the specialty restaurant ‘Sabeki’ and the flagship Balaram Mallick Radharaman Mallick sweet shop, claimed that the number of tourists visiting the city during the Durga Puja season has significantly decreased compared to previous years.

Siddhartha Gupta, co-founder of Traffic Gastropub, said, “The ongoing movement has affected different parts of the city, but Traffic Gastropub has not felt the tremor in that way. However, we have noticed a dip in footfall during our Happy Hour and late-night hours.”

“As a result, our overall return on investment (ROI) has decreased by around 5-10 per cent. However, we are hopeful that the Durga Puja days will bring a positive boost to sales, which we are already witnessing,” he said.

Traffic Gastropub is located in a shopping mall in the New Town area, a satellite township near the city.

Gupta emphasised, “We are focusing on creating a special festive menu to enhance the dining experience. Given our strong presence in the mall, we anticipate a gradual recovery, with sales during the festive season likely helping to offset the recent dip caused by the ongoing movements”, news agency PTI reported.

Swastik Nag, founder of Canteen Pub and Grub, remarked, “The ongoing movements in the city have impacted the overall mood across various sections of society.”

He noted a decline in footfall from different customer groups, stating, “Whether college students, homemakers, or the usual nightlife crowd, all had been more hesitant to venture out until a few days ago, though things are looking up now.”

Nag added, “We cater to a diverse clientele, including professionals from nearby corporate offices and medical institutions. Overall, our ROI has dropped by approximately 20-30 per cent, affecting both sales and supply chain management.”

Despite the protests, weekend footfall has been witnessing an upswing, particularly during weekends, while weekday sales remain sluggish, he added.

Nag expressed cautious optimism for the Durga Puja days.

“The scale of celebrations may be more modest than Kolkata typically witnesses, but we still expect a recovery in sales during the festival period,” he said.

Azra Golam, director of Aminia Restaurants, stated, “The food and beverage industry has been significantly impacted by the ongoing protests, resulting in a 10-15 per cent decline in sales.”

She added, “We empathise with the city’s focus on justice and hope for a swift resolution, but we also wish that our outlets are filled and our tables occupied during the four days with renewed optimism.”

Co-founders of Yellow Straw, Vikram Khinwasara and Piyush Kankaria, commented, “The ongoing protests in West Bengal over the incident at RG Kar Medical College and Hospital have impacted the state’s Durga Puja economy, including the F&B industry in a significant way.”

“Consumer demand has declined, and footfalls in malls and shopping hubs have been significantly lower than usual. Traffic snarls due to protests are also adding to the woes of the food and beverage industry. Currently, sales have dipped by almost 25 per cent,” they said.

Despite the challenges, they expressed hope over the four days of festivities starting Wednesday.

“In West Bengal, we are always optimistic whenever Durga Puja is around the corner. The crowd is back at the pandals and restaurants, so we are hopeful about a positive response during the puja days,” they said.

Co-founders of Craft Coffee, Abhinav Kumar and Dipraj Das, remarked, “Due to the recent events related to the RG Kar protest, our outlets experienced a temporary decline in traffic. However, we’re encouraged to see a revival in both café visits and online deliveries in recent times.”

The city has been witnessing protests and rallies demanding justice for the woman medic, who was allegedly raped and murdered at RG Kar Hospital in August.

Also Read:RG Kar doctor murder case: Junior Doctors allege being lathi-charged by police during protest

Powered by WPeMatico

174-bed cancer hospital coming up at cost of Rs 213 crores in Bandra West

Mumbai: In a significant advancement in healthcare, the foundation stone for a 174-bed cancer hospital at Bandra West was laid by MLA Ashish Shelar on Tuesday. This new cancer hospital is set to provide comprehensive care with modern treatment protocols to patients. 

Also Read: Odisha CM lays foundation stone for Tata Cancer Hospital

Following the excessive load in the Tata Memorial Hospital, the new cancer hospital is set with an investment of 213 crores and is expected to provide treatment to the patients who come to the city seeking cancer treatment. The new facility will help the patients to get timely diagnosis and proper treatment, potentially saving thousands of lives. The construction of this 13-story building is expected to be completed within 36 months. MLA Ashish Shelar laid the foundation stone of this hospital.

According to the Times of India reports the hospital will come up opposite the Bhabha Hospital and will be a state-of-the-art cancer care facility with an intensive care unit. There will be two basements and a built-up area of around 13 thousand square meters. The building will have two bunker rooms for radiation therapy, 12 OPD wards, and five laboratories, including those for biochemistry, histopathology, haematology, and microbiology, apart from mammography and PET-CT units. 

In addition to the treatment areas, the new hospital will also boast a range of essential facilities, including a lecture hall, seminar hall, blood bank, and isolation rooms. This 174-bed new hospital facility is designed to provide cancer care and will also provide accommodations to the patients and their families. The hospital facility will be located on the first to eighth floors, giving comprehensive care to cancer patients, while the ninth and tenth floors will be used as accommodation for the hospital staff. Many key officials were present during the Bhumipujan ceremony, including BMC H-West Ward Officer Vinayak Vispute, along with leaders from the BJP and Shiv Sena.

Also Read: NAGPUR: New cancer facility coming up

This upcoming hospital is designed by the Municipal Architect Department. As per the designs, the hospital will offer a range of facilities, including an intensive care unit (ICU) and high dependency units (HDUs). Additionally, the hospital will also offer a range of treatments, including chemotherapy, brachytherapy, and radiation therapy, among other things, positioning it as a comprehensive cancer care centre.

Powered by WPeMatico

Anti cancer medicines now under Schedule H2 of Drugs Rules, Here is what it means

New Delhi: In order to track the movement of anti-cancer drugs and prevent counterfeiting, the Drug Technical Advisory Board (DTAB) has agreed to include all anti cancer medicines under Schedule H2 of Drugs Rules, 1945. With this, all manufacturers of anti cancer medicines will now be required to print or affix a barcode or QR code on the labels of their products.

This decision comes in response to reports of unscrupulous criminals refilling empty vials of expensive anti-cancer drugs with counterfeit medications. These fake drugs were then mixed with genuine stocks and sold to unsuspecting cancer patients and putting their life at risk.

What is Schedule H2?

The Ministry of Health and Family Welfare had notified the Drugs (Eight Amendment) Rules, 2022 (“Amendment Rules”) on November 17, 2022, which amended the Drugs and Cosmetics Rules, 1945 to insert a new labelling requirement for drug formulation products specified under Schedule H2 of the DnC Rules. The Amendment Rules came into force on August 01, 2023.

Schedule H2 contains a list of 300 drugs which are required to be in compliance with the Amendment Rules.

The manufacturers of drug formulation products as specified in Schedule H2 have to print or affix Bar Code or Quick Response Code on its primary packaging label or, in case of inadequate space in primary package label, on the secondary package label that store data or information legible with software application to facilitate authentication.

This enables storage of data or information regarding the product, readable with software application to facilitate tracking and tracing of the product. The stored data associated with the QR code include certain minimum particulars prescribed, which include proper and generic name of the drugs, unique product identification code, brand name, batch number, date of manufacturing, date of expiry, name and address of the manufacturer, etc.

Read Also: Union Health Ministry notifies 300 drug brands under Schedule H2, Details

Earlier this year, Medical Dialogues team had reported that the crime branch of Delhi Police had busted a counterfeit cancer drug racket, arresting seven individuals for producing and selling fake cancer and chemotherapy medicines. Among the counterfeit drugs were Keytruda and Opdyta, typically used to treat cancer. These fake medicines were sold at high prices to unsuspecting patients. Police recovered fake drugs worth Rs 4 crore, along with packaging materials and empty vials, during raids.

Also Read: Delhi Police cracks down on fake cancer drug racket

In view of such events, the Drug Technical Advisory Board (DTAB) in its 91st meeting on August 14, 2024, considered and approved the proposal for track and trace mechanism for oncology products by providing quick response and bar code.

“These anti-cancer drugs must be issued under strict directives to implement mandatory QR codes and rigorous track and trace mechanisms on every vial and strip of medication that are marketed in India.”

Accordingly, Schedule H2 of Drugs Rules, 1945 will be now amended to include all Anticancer medicines to have mandatory provision to print or affix Bar Code or Quick Response Code in its labels.

Powered by WPeMatico

Lack of Postmortem Facilities: Calcutta HC directs Centre to bring AIIMS Kalyani at par with Delhi AIIMS

Kolkata: When heard about the lack of a postmortem facility at a premier institute like All India Institute of Medical Sciences (AIIMS) Kalyani, the Calcutta High Court conveyed its astonishment and directed the Centre to enhance the infrastructure of AIIMS Kalyani in West Bengal to match that of AIIMS in Delhi by December 2025.

During the hearing session, a bench of Justice Tirthankar Ghosh observed, “This is surprising that till date there is no infrastructure for conducting post-mortem examination at AIIMS, Kalyani and the infrastructure of a tertiary referral hospital like J.N.M. Hospital, Kalyani had to be used for post mortem examination by the doctors of AIIMS, Kalyani.” 

The court was hearing a matter concerning the rape and murder of a schoolgirl in West Bengal’s Jayanagar. The high court was told that AIIMS Kalyani lacked the infrastructure to carry out a post-mortem, following which the examination had to be conducted in another nearby hospital.  

Also read- Allegations of Threat Culture’ in Bengal medical colleges: Calcutta HC directs Govt to file affidavit

“The word “All India Institute of Medical Sciences” refers to a premier brand health organisation, where a common man can have the services of the best of the doctors available in the Country. The institute is not restricted only to academic purposes but also to rendering services to patients who are suffering from acute diseases. If an AIIMS is situated within a State the common man at large should be benefited by the services of the best of the doctors who are ready, but they are not having a support system to execute their ability,” stated the court as quoted by ABP Live news report.  

Further, it added, “The institution has been offering courses to best of the students across the Country at the Graduation and Post-graduation level in the field of medical sciences. So far as the services to the citizen at large are concerned, the confidence must be reposed that every infrastructure and facility is made available within the boundary and premises of AIIMS, Kalyani.”

The court termed the information as disheartening and surprising. Later, it directed the Secretary of the Ministry of Health and Family Welfare, Government of India, to evaluate the deficiencies in infrastructure at AIIMS, Kalyani, ensuring that the facilities are developed to match those of AIIMS, Delhi, or AIIMS, Rishikesh.

“Steps be taken by the Ministry of Health and Family Welfare, Government of India to complete the infrastructure preferably by 31st December 2025. In case any permission, license is to be granted by the State Government no deterrence or hindrance be created in granting of such license to the authorities of AIIMS, Kalyani. The State would cooperate for facilitating the services of AIIMS, Kalyani to the common people at large.”

Also read- Ex-colleague moves HC seeking ED probe into alleged financial irregularities by Former RG Kar Principal

Powered by WPeMatico

The 50 by 50 goal: Report explores how to reduce probability of dying before age 70 by 50% globally by 2050

A team of 50 leading international experts, The Lancet Commission on Investing in Health (CIH), explored this question, resulting in clear, actionable, and achievable measures for achieving this ambitious goal worldwide.

Powered by WPeMatico

Evidence builds for near infrared light treatment in traumatic brain injury

Birmingham scientists have shown light therapy delivered transcranially (through the skull) can aid tissue repair after mild traumatic brain injury (mTBI).

Powered by WPeMatico